Abstract
The aim of this study was to evaluate the effect of estrogen on matrix metalloproteinase (MMP)-1, MMP-3, MMP-13, and tissue inhibitor of metalloproteinase (TIMP)-1 in osteoarthritic chondrocytes. Chondrocytes from the knee cartilage of 25 postmenopausal osteoarthritic (OA) patients were cultured under various conditions: 0 pg/mL, 50 pg/mL, 500 pg/mL, and 5,000 pg/mL of 17β-estradiol, with or without 10–1,000 pg/mL of either interleukin (IL)-1β or tumor necrosis factor alpha (TNFα). MMP-1, MMP-3, MMP-13, and TIMP-1 in the conditioned media were analyzed with immunoblot or enzyme-linked immunosorbent assay (ELISA). Type II collagenolytic activity was measured by fluorogenic type II collagenolytic activity assay. Real-time reverse transcriptase polymerase chain reaction (RT-PCR) using SYBR Green I dye was performed for the quantification of mRNA. Without cytokine stimulation, the secretion of MMP-1 was significantly reduced by 50 pg/mL of 17β-estradiol (in immunoblot by a median of 12.3%, P=0.007; in ELISA by a median of 18.4%, P=0.001), and 500 pg/mL (in immunoblot by a median of 23.1%, P=0.001; in ELISA by a median of 21.0%, P=0.001). Additionally, under 10 pg/mL TNFα, 17β-estradiol also significantly suppressed the secretion of MMP-1 (in immunoblot by a median of 39.0%, P=0.016; in ELISA by a median of 38.4%, P=0.041). Estrogen did not exert any significant effect on MMP-3, MMP-13, or TIMP-1 expression. With IL-1β or TNFα above 10 pg/mL stimulation, 17β-estradiol demonstrated no effect on MMP-1, MMP-3, MMP-13, or TIMP-1 secretion. Type II collagenolytic activity in the 50 pg/mL estradiol group decreased by 9.6% (−51.5–5.5%, P>0.05). 17β-estradiol showed a tendency to decrease in MMP-1 mRNA. Estrogen may improve the imbalance between the amounts of MMPs and TIMP in chondrocytes, and these results suggest that hormone replacement therapy may provide some chondroprotective effect.
Similar content being viewed by others
References
Felson DT, Nevitt CM (1998) The effects of estrogen on osteoarthritis. Curr Opin Rheumatol 10:269–272
Dean DD, Martel-Pelletier J, Pelletier JP, Howell DS, Woessner JF (1989) Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 84:678–685
Martel-Pelletier J, McCollum R, Fujimoto N, Obata K, Cloutier JM, Pelletier JP (1994) Excess of metalloproteinases over tissue inhibitor of metalloproteinase may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab Invest 70:807–815
Kapila S, Xie Y (1998) Targeted induction of collagenase and stromelysin by relaxin in unprimed and beta-estradiol-primed diarthrodial joint fibrocartilagenous cells but not in synovitis. Lab Invest 78:925–938
Pezzetti F, De Mattei M, Caruso A, Cadossi R, Zucchini P, Carinci F, Traina GC, Sollazzo V (1999) Effects of pulsed electromagnetic fields on human chondrocytes: an in vitro study. Calcif Tissue Int 65:396–401
Murawaki Y, Koda M, Yamada S, Kawasaki H, Shima H, Burkhardt H (1993) Serum collagenase activity in patients with chronic liver disease. J Hepatol 18:328-334
Spector TD, Nandra D, Hart DJ, Doherty M (1997) Is hormone replacement therapy protective for hand and knee osteoarthritis in women? The Chingford Study. Ann Rheum Dis 56:432–434
Zhang Y, McAlindon T, Hannan MT, Chaisson CE, Klein R, Wilson PW, Felson DT (1998) Estrogen replacement therapy and worsening of radiographic knee osteoarthritis: The Framingham Study. Arthritis Rheum 41:1867–1873
Hart DJ, Doyle DV, Spector TD (1999) Incidence and risk factors for radiographic knee osteoarthritis in middle-aged women: the Chingford Study. Arthritis Rheum 42:17–24
Hannan MT, Felson DT, Anderson JJ, Naimark A, Kannel WB (1990) Estrogen use and radiographic osteoarthritis of the knee in women. The Framingham Osteoarthritis Study. Arthritis Rheum 33:525–532
Samanta A, Jones A, Regan M, Wilson S, Doherty M (1993) Is osteoarthritis in women affected by hormonal changes or smoking? Br J Rheumatol 32:366–370
Erb A, Brenner H, Gunther KP, Sturmer T (2000) Hormone replacement therapy and patterns of osteoarthritis: baseline data from the Ulm Osteoarthritis Study. Ann Rheum Dis 59:105–109
Tsai CL, Liu TK, Chen TJ (1992) Estrogen and osteoarthritis: a study of synovial estradiol and estradiol receptor binding in human osteoarthritis knees. Biochem Biophys Res Commun 183:1287–1291
Cauley JA, Kwoh CK, Egeland G, Nevitt MC, Cooperstein L, Rohay J, Towers A, Gutai JP (1993) Serum sex hormones and severity of osteoarthritis of the hand. J Rheumatol 20:1170–1175
Sowers MF, Hochberg M, Crabbe JP, Muhich A, Crutchfield M, Updike S (1996) Association of bone mineral density and sex hormone levels with osteoarthritis of the hand and knee in premenopausal women. Am J Epidemiol 143:38–47
Roaner I. Goldberg VM, Moskowitz RW (1979) Effects of estrogens on cartilage and experimentally induced osteoarthritis. Arthritis Rheum 22:52–58
Rosner IA, Malemud CJ, Godberg VM, Papay RS, Getzy L, Moskowitz RW (1982) Pathologic and metabolic responses of experimental osteoarthritis to estradiol and an estradiol antagonist. Clin Orthop 171:280–286
Tsai CL, Liu TK (1992) Inhibition of estradiol-induced early osteoarthritic changes by tamoxifen. Life Sci 50:1943–1951
Levrant SG, Barnes RB (1994) Pharmacology of estrogens. In: Lobo RA (ed) Treatment of postmenopausal woman. First edn. Raven Press, New York, pp 57–89
Hsueh AW, Billing H (1995) Ovarian hormone synthesis and mechanism of action. In: DeGroot LJ (ed) Endocrinology. Third edn. Saunders, Philadelphia, pp 2019–2030
Challis JR, Davies J, Ryan KJ (1973) The concentrations of progesterone, estrone and estradiol-17 beta in the plasma of pregnant rabbits. Endocrinology 93:971–976
Kahle P, Saal JG, Schaudt K, Zacher J, Fritz P, Pawelec G (1992) Determination of cytokines in synovial fluids: correlation with diagnosis and histomorphological characteristics of synovial tissue. Ann Rheum Dis 51:731–734
Manicourt DH, Poilvache P, Van Egeren A, Devogelaer JP, Lenz ME, Thonar EJ (2000) Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis. Arthritis Rheum 43:281–288
Goldring MB (1999) The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models. Connect Tissue Res 40:1–11
Wluka AE, Davis SR, Bailey M, Stuckey SL, Cicuttini FM (2001) Users of oestrogen replacement therapy have more knee cartilage than non-users. Ann Rheum Dis 60:332–336
Nevitt MC, Felson DT, Williams EN, Grady D (2001) The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 44:811-818
Ham KD, Loeser RF, Lindgren BR, Carlson CS (2002) Effects of long-term estrogen replacement therapy on osteoarthritis severity in cynomolgus monkeys. Arthritis Rheum 46:1956–1964
Su S, Grover J, Roughley PJ, DiBattista JA, Martel-Pelletier J, Pelletier JP, Zafarullah M (1999) Expression of the tissue inhibitor of metalloproteinases (TIMP) gene family in normal and osteoarthritic joints. Rheumatol Int 18:183–191
Ushiyama T, Ueyama H, Inoue K, Ohkubo I, Hukuda S (1999) Expression of genes for estrogen receptors alpha and beta in human articular chondrocytes. Osteoarthritis Cartilage 7:560–566
Kelly MJ, Levin ER (2001) Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab 12:152–156
Mengshol JA, Vincenti MP, Coon CI, Barchowsky A, Brinckerhoff CE (2000) Interleukin-1 induction of collagenase-3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-JUN N-terminal kinase, and nuclear factor κB. Arthritis Rheum 43:801–811
Fernihough JK, Richmond RS, Carlson CS, Cherpes T, Holly JM, Loeser RF (1999) Estrogen replacement therapy modulation of the insulin-like growth factor system in monkey knee joints. Arthritis Rheum. 42:2103–2111
Richmond RS, Carlson CS, Register TC, Shanker G, Loeser RF (2000) Functional estrogen receptors in adult articular cartilage: estrogen replacement therapy increases chondrocyte synthesis of proteoglycans and insulin-like growth factor binding protein 2. Arthritis Rheum 43:2081–2090
Acknowledgements
We are grateful for the excellent technical help in real-time RT-PCR of M. Kinoshita Ph.D., Gene Diagnostic Center, Otsuka Assay Laboratories, Tokushima, Japan, and invaluable discussions on the results with K.A. Hasty Ph.D. and A.H. Kang MD Ph.D. of the University of Tennessee, USA.
This work was supported by a grant from the Korea Heath 21 R&D project, Ministry of Health and Welfare, Republic of Korea (HMP-00-C11–08–0007) and partially by the Basic Research Program of the Korea Science and Engineering Foundation, Korea (2000–215–001–3).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, Y.J., Lee, E.B., Kwon, Y.E. et al. Effect of estrogen on the expression of matrix metalloproteinase (MMP)-1, MMP-3, and MMP-13 and tissue inhibitor of metalloproternase-1 in osteoarthritis chondrocytes. Rheumatol Int 23, 282–288 (2003). https://doi.org/10.1007/s00296-003-0312-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-003-0312-5